HELLINGS, Niels

Email Alert RSS Feed

Profile

Full Name
HELLINGS, Niels
Email
niels.hellings@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 193-217 of 217 (Search time: 0.008 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1932006T-cell vaccination in MS with CSF-derived activated CD4(+) T-cells: Results of a placebo-controlled trialSTINISSEN, Piet; MEDAER, Rob; HELLINGS, Niels; Barkhof, F.; RAUS, JefJournal ContributionM
1942006Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
1952006Secondary progressive in contrast to relapsing - Remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T cell function and FOXP3 expressionVENKEN, Koen; HELLINGS, Niels; HENSEN, Karen; RUMMENS, Jean-Luc; MEDAER, Rob; D'hooghe, MB; Dubois, B; RAUS, Jef; STINISSEN, PietJournal ContributionM
1962006Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-α-induced oligodendrocyte apoptosisVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; VANDENABEELE, Frank; MOREELS, Marjan; BUNTINX, Mieke; Hoekstra, D.; Antel, J.; STINISSEN, PietJournal ContributionA1
1972006Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4(+)CD25(+) regulatory T-Cell function and FOXP3 expressionVENKEN, Koen; HELLINGS, Niels; HENSEN, Karen; RUMMENS, Jean-Luc; MEDAER, Rob; D'hooghe, M.; Dubois, W.; RAUS, Jef; STINISSEN, PietJournal ContributionA1
1982006T cell vaccination in multiple sclerosis with CSF-derived activated cd4+T cells: results of a placebo-controlled trialSTINISSEN, Piet; MEDAER, Rob; HELLINGS, Niels; VANROOSE, Erwin; Barkhof, F.; RAUS, JefJournal ContributionM
1992006T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccinationHELLINGS, Niels; RAUS, Jef; STINISSEN, PietJournal ContributionA2
2002005Profiling the autoantibody repertoire by serological antigen selectionSOMERS, Veerle; GOVARTS, Cindy; HELLINGS, Niels; Hupperts, R.; STINISSEN, PietJournal ContributionA1
2012005Diffusion of sphingomyelin and myelin oligodendrocyte glycoprotein in the membrane of OLN-93 oligodendroglial cells studied by fluorescence correlation spectroscopyGIELEN, Ellen; Vercammen, J; Sykora, J; Humpolickova, J; VAN DE VEN, Martin; Benda, A.; HELLINGS, Niels; Hof, M; Engelborghs, Y; STEELS, Paul; AMELOOT, MarcelJournal ContributionA1
2022004Impaired suppressive capacity and reduced FOXP3 expression of CD4+CD25+ regulatory T cells isolated from multiple sclerosis patientsVENKEN, Koen; HELLINGS, Niels; SCHUERMANS, Joke; RAUS, Jef; STINISSEN, PietJournal ContributionM
2032004Anti-ergotypic T cell responses in healthy controls and multiple sclerosis patientsHELLINGS, Niels; GOVARTS, Cindy; RAUS, Jef; STINISSEN, PietJournal ContributionM
2042004Leukemia inhibitory factor is produced by myelin reactive T-cells and protects against cytokine induced oligodendrocyte cell deathVANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; MOREELS, Marjan; Antel, J.; RAUS, Jef; STINISSEN, PietJournal ContributionM
2052004T-cell vaccination in multiple sclerosis: update on clinical application and mode of actionHELLINGS, Niels; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2062003Effects of prolactin on cloned human T-LymphocytesDogusan, Z; Martens, N; STINISSEN, Piet; HELLINGS, Niels; Demotte, N; Hooghe, R; Hooghe-Peters, ELJournal ContributionA1
2072003Long-term effects of T cell vaccination in multiple sclerosisSTINISSEN, Piet; HERMANS, Guy; HELLINGS, Niels; MEDAER, Rob; RAUS, JefProceedings PaperC1
2082003T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot studyVAN DER AA, Annegret; HELLINGS, Niels; MEDAER, Rob; Gelin, G; PALMERS, Yvan; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2092003Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controlsVAN DER AA, Annegret; HELLINGS, Niels; Bernard, C.C.A.; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2102003Potential role for neuropoietic factors in protecting oligodendrocytes from cytokine induced damageVANDERLOCHT, Joris; HELLINGS, Niels; Dreesen, E; BUNTINX, Mieke; DE RYCK, Leen; RAUS, Jef; STINISSEN, PietJournal ContributionM
2112003Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expressionBUNTINX, Mieke; VANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; LAMBRICHTS, Ivo; RAUS, Jef; AMELOOT, Marcel; STINISSEN, Piet; STEELS, PaulJournal ContributionA1
2122002Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis association with clinical and MRI activityHELLINGS, Niels; Gellin, G.; MEDAER, Rob; BRUCKERS, Liesbeth; PALMERS, Yvan; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2132002Insights into the immunopathogenesis of multiple sclerosisHELLINGS, Niels; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2142001Promotieonderzoek: studie van de anti-myeline T-celreactiviteit en regulatorische netwerken in multiple scleroseHELLINGS, NielsJournal ContributionA3
2152001T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controlsHELLINGS, Niels; Baree, M.; Verhoeven, C; D'hooghe, MB; MEDAER, Rob; Bernard, C.C.A.; RAUS, Jef; STINISSEN, PietJournal ContributionA1
2162000Study of Anti-Myelin T Cell Reactivity and Regulatory Networks in Multiple SclerosisHELLINGS, NielsTheses and DissertationsT1
2171997Functional redundancy of genes for sulphate activation enzymes in Rhizobium sp. BR816.Laeremans, T; Coolsaet, N; Verreth, C; Snoeck, C; HELLINGS, Niels; Vanderleyden, J; Martinez-Romero, EJournal Contribution
show all